Goldman Sachs Downgrades Lantheus Holdings (LNTH) to Neutral

Goldman Sachs analyst Paul Choi downgraded Lantheus Holdings (NASDAQ: LNTH) from Buy to Neutral with a price target of $77.00 (from $110.00).

The analyst comments: "We see modest risk to intermediate-term consensus sales estimates; stock recovery tied to improving visibility on organic growth. Year-to-date, LNTH shares have significantly underperformed due to lingering pricing pressure on Pylarify, slower-than-anticipated uptake of approved Alzheimer's disease therapeutics, and a series of bolt-on acquisitions that have made the drivers of the company's future growth less predictable. While we see a mostly balanced risk/reward at current levels, a more sustained recovery in the stock is contingent upon improved visibility on organic growth, in our view. We downgrade LNTH to Neutral from Buy with a new 12-month price target of $77 (from $110 prior)."

For an analyst ratings summary and ratings history on Lantheus Holdings click here. For more ratings news on Lantheus Holdings click here.

Shares of Lantheus Holdings closed at $51.84 yesterday.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Air T reports revenue jump but widens operating loss in Q1 fiscal 2027
• Cantor Fitzgerald Reiterates Overweight Rating on Applied Materials (AMAT)